PMID- 18639596 OWN - NLM STAT- MEDLINE DCOM- 20090709 LR - 20181201 IS - 1873-4995 (Electronic) IS - 0168-3659 (Linking) VI - 132 IP - 3 DP - 2008 Dec 18 TI - Dendritic multishell architectures for drug and dye transport. PG - 289-94 LID - 10.1016/j.jconrel.2008.06.016 [doi] AB - Here we present the efficiency and versatility of newly developed core-multishell nanoparticles (CMS NPs), to encapsulate and transport the antitumor drugs doxorubicin hydrochloride (Dox), methotrexate (Mtx) and sodium ibandronate (Ibn) as well as dye molecules, i.e., a tetrasulfonated indotricarbocyanine (ITCC) and nile red. Structurally, the CMS NPs are composed of hyperbranched poly(ethylene imine) core functionalized by alkyl diacids connected to monomethyl poly(ethylene glycol). In order to evaluate their transport in aqueous media in vitro, we have used and compared SEC, UV, ITC, and NMR techniques. We observed that the CMS NPs were able to spontaneously encapsulate and transport Dox, Mtx and nile red in both organic and aqueous media as determined by SEC and UV-VIS spectroscopy. For the VIS transparent Ibn Isothermal Titration Calorimetric (ITC) experiments show an exothermic interaction with the CMS NPs. The enthalpic stabilization (DeltaH) upon encapsulation was in the order of approximately 7 kcals/mol which indicates stable interaction between Ibn and nanoparticles. A T(1) inversion recovery NMR experiment was carried out for 31P and 1H nuclei of Ibn and an increment of spin-lattice relaxation time for respective nuclei was observed upon encapsulation. CMS NPs were also found to encapsulate ITCC dye with stoichiometry of 6-8 molecules/nanocarrier. For in vivo imaging studies the dye loaded CMS NPs were injected to F9 teratocarcinoma bearing mice and a strong contrast was observed in the tumor tissues compared to free dye after 6 h of administration. FAU - Quadir, Mohiuddin A AU - Quadir MA AD - Institut fur Chemie und Biochemie, Freie Universitat Berlin, Takustrasse 3, 14195 Berlin, Germany. FAU - Radowski, Michal R AU - Radowski MR FAU - Kratz, Felix AU - Kratz F FAU - Licha, Kai AU - Licha K FAU - Hauff, Peter AU - Hauff P FAU - Haag, Rainer AU - Haag R LA - eng PT - Comparative Study PT - Journal Article DEP - 20080623 PL - Netherlands TA - J Control Release JT - Journal of controlled release : official journal of the Controlled Release Society JID - 8607908 RN - 0 (Antineoplastic Agents) RN - 0 (Carbocyanines) RN - 0 (Coloring Agents) RN - 0 (Diphosphonates) RN - 0 (Drug Carriers) RN - 0 (Oxazines) RN - 0 (indotricarbocyanine) RN - 3WJQ0SDW1A (Polyethylene Glycols) RN - 80168379AG (Doxorubicin) RN - 9002-98-6 (Polyethyleneimine) RN - P476F1L81G (nile red) RN - UMD7G2653W (Ibandronic Acid) RN - YL5FZ2Y5U1 (Methotrexate) SB - IM MH - Animals MH - Antineoplastic Agents/chemistry/*metabolism MH - Calorimetry MH - Carbocyanines/metabolism MH - Chemistry, Pharmaceutical MH - Chromatography, Gel MH - Coloring Agents/administration & dosage/chemistry/*metabolism/pharmacokinetics MH - Diphosphonates/metabolism MH - Doxorubicin/metabolism MH - *Drug Carriers MH - Drug Compounding MH - Ibandronic Acid MH - Injections, Intravenous MH - Magnetic Resonance Spectroscopy MH - Methotrexate/metabolism MH - Mice MH - *Nanoparticles MH - Oxazines/metabolism MH - Polyethylene Glycols/*chemistry MH - Polyethyleneimine/*chemistry MH - Spectrophotometry, Ultraviolet MH - Technology, Pharmaceutical/methods MH - Teratocarcinoma/metabolism EDAT- 2008/07/22 09:00 MHDA- 2009/07/10 09:00 CRDT- 2008/07/22 09:00 PHST- 2008/04/29 00:00 [received] PHST- 2008/06/13 00:00 [revised] PHST- 2008/06/16 00:00 [accepted] PHST- 2008/07/22 09:00 [pubmed] PHST- 2009/07/10 09:00 [medline] PHST- 2008/07/22 09:00 [entrez] AID - S0168-3659(08)00345-3 [pii] AID - 10.1016/j.jconrel.2008.06.016 [doi] PST - ppublish SO - J Control Release. 2008 Dec 18;132(3):289-94. doi: 10.1016/j.jconrel.2008.06.016. Epub 2008 Jun 23.